BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18393608)

  • 1. Heat-shock protein-based vaccines for cancer and infectious disease.
    Binder RJ
    Expert Rev Vaccines; 2008 Apr; 7(3):383-93. PubMed ID: 18393608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein vaccines: from bench to bedside.
    Binder RJ
    Int Rev Immunol; 2006; 25(5-6):353-75. PubMed ID: 17169780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heat shock proteins and their role in the development of pathological processes].
    Malaĭtsev VV; Bogdanova IM; Makarova OV
    Arkh Patol; 2008; 70(6):31-8. PubMed ID: 19227279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat-shock proteins as powerful weapons in vaccine development.
    Bolhassani A; Rafati S
    Expert Rev Vaccines; 2008 Oct; 7(8):1185-99. PubMed ID: 18844593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens.
    Srivastava PK
    Methods; 1997 Jun; 12(2):165-71. PubMed ID: 9184380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock proteins as vaccine adjuvants in infections and cancer.
    Segal BH; Wang XY; Dennis CG; Youn R; Repasky EA; Manjili MH; Subjeck JR
    Drug Discov Today; 2006 Jun; 11(11-12):534-40. PubMed ID: 16713905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic cancer vaccines: using unique antigens.
    Lewis JJ
    Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14653-6. PubMed ID: 15297620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in heat shock protein-based cancer vaccines.
    Wang HH; Mao CY; Teng LS; Cao J
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):22-7. PubMed ID: 16481277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous renal cell cancer vaccines using heat shock protein-peptide complexes.
    Aalamian M; Fuchs E; Gupta R; Levey DL
    Urol Oncol; 2006; 24(5):425-33. PubMed ID: 16962495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsp receptors: the cases of identity and mistaken identity.
    Binder RJ
    Curr Opin Mol Ther; 2009 Feb; 11(1):62-71. PubMed ID: 19169961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications.
    Hoos A; Levey DL
    Expert Rev Vaccines; 2003 Jun; 2(3):369-79. PubMed ID: 12903802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein-based cancer vaccines.
    Oki Y; Younes A
    Expert Rev Vaccines; 2004 Aug; 3(4):403-11. PubMed ID: 15270645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvants for vaccines, a quest.
    Audibert F
    Int Immunopharmacol; 2003 Aug; 3(8):1187-93. PubMed ID: 12860174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation.
    Murshid A; Gong J; Calderwood SK
    Expert Rev Vaccines; 2008 Sep; 7(7):1019-30. PubMed ID: 18767951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock proteins: applications in health and disease.
    Jindal S
    Trends Biotechnol; 1996 Jan; 14(1):17-20. PubMed ID: 8579818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I interferons as vaccine adjuvants against infectious diseases and cancer.
    Bracci L; La Sorsa V; Belardelli F; Proietti E
    Expert Rev Vaccines; 2008 Apr; 7(3):373-81. PubMed ID: 18393607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current ideas about applications of heat shock proteins in vaccine design and immunotherapy.
    Wang XY; Li Y; Yang G; Subjeck JR
    Int J Hyperthermia; 2005 Dec; 21(8):717-22. PubMed ID: 16338854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat-shock proteins as drugs: potential applications in cancer, infections, and autoimmune and atopic diseases.
    Holzer AM; Martiniuk F; Levis WR
    J Drugs Dermatol; 2007 Apr; 6(4):393-9. PubMed ID: 17668536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock proteins gp96 as immunogens in cancer patients.
    Parmiani G; De Filippo A; Pilla L; Castelli C; Rivoltini L
    Int J Hyperthermia; 2006 May; 22(3):223-7. PubMed ID: 16754342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble low-molecular-mass heat shock proteins and tumor-associated antigens in prevention and therapy of chemically-induced cancers.
    Zusman I; Kossoy G; Ben-Hur H
    In Vivo; 2001; 15(6):529-34. PubMed ID: 11887340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.